HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Sponsor: 35Pharma Inc
Kansas City, MO · Greenville, SC
9 recruiting Phase 1/2 hypertension studies in the US. What trial phases mean
Sponsor: 35Pharma Inc
Kansas City, MO · Greenville, SC
Sponsor: 35Pharma Inc
Tampa, FL · Providence, RI
Sponsor: Astellas Pharma Global Development, Inc.
Boston, MA
Sponsor: CRISPR Therapeutics AG
Port Orange, FL
Sponsor: University of Texas Southwestern Medical Center
Dallas, TX
Sponsor: Novartis Pharmaceuticals
Scottsdale, AZ · Orange, CA · Stanford, CA · +17 more sites
Sponsor: University of Pennsylvania
Philadelphia, PA
Sponsor: Vanderbilt University Medical Center
Nashville, TN
Sponsor: University of North Texas Health Science Center
Fort Worth, TX
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.